The Phase II randomized controlled clinical study to evaluate pharmacodynamics of micro-formulation over conventional eyedroppers.
Phase of Trial: Phase II
Latest Information Update: 20 Dec 2016
At a glance
- Drugs Phenylephrine/tropicamide (Primary)
- Indications Mydriasis
- Focus Pharmacodynamics
- 20 Dec 2016 Positive results published in an Eyenovia media release.
- 06 Dec 2016 New trial record
- 28 Nov 2016 According to Eyenovia media release, results were published in the peer-review journal Therapeutic Delivery.